Drugs / 3H-cholesterol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01782027 | Oct 2012 → Sep 2024 | LCAT deficiency, Tangier disease, cholesterol-ester transfer protein deficiency | University of Pennsylvania | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3H-cholesterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01782027 ↗ |
| Route | Intravenous | “will be administered as an intravenous bolus injection” NCT01782027 ↗ |